Exelon Corporation (EXC) has been showing consistent performance in the stock market. Multiple institutional investors, making up approximately
84-86% ownership, express their confidence in the company. Despite experiencing some losses and a cyber outage, the corporation continued to outperform competitors on significant trading days and showed positive daily gains.
O Shaughnessy Asset Management LLC, CreativeOne Wealth LLC, Acadian Asset Management LLC, and other institutional giants have expressed their backing by either purchasing or raising holdings in this company. The growth momentum of
EXC seems to be on a raised trajectory, and their previous records show a healthy
CAGR of 5.9% over the last three years, and a 25% gain over five years. Their management is doing well with a return on equity of 8.9%. EXC also beat sales estimates and declared healthy dividends. They announced organisational changes and are actively working towards an equitable energy transformation via infrastructure funding. This bio-tech giant has an average rating of 'Hold' by analysts but has managed to maintain its value as a preferred choice among institutional investors.
Exelon Corporation EXC News Analytics from Tue, 10 Nov 2020 08:00:00 GMT to Sun, 28 Jul 2024 16:05:15 GMT -
Rating 5
- Innovation -2
- Information 8
- Rumor -4
